Peer-influenced content. Sources you trust. No registration required. This is HCN.
Cleveland Clinic Journal of Medicine
Post-trial analysis reveals a 13% relative reduction in cardiovascular death and kidney disease progression risk, though this benefit primarily manifests in the first 12 months after treatment discontinuation.
Cardiology December 10th 2024
Facty Health
Anti-inflammatory compounds in specific foods demonstrate protective effects against kidney damage while maintaining safe mineral levels for compromised renal function.
Internal Medicine November 21st 2024
The New England Journal of Medicine
In patients with heart failure and preserved ejection fraction, finerenone demonstrated a 16% reduction in the primary composite endpoint of total worsening heart failure events and cardiovascular death compared to placebo.
Cardiology October 28th 2024
MDLinx
Less than half of the 26,000 annual rhabdomyolysis cases in the United States are exercise-related, but early recognition remains crucial for preventing severe complications.
Emergency Medicine October 23rd 2024
Medical Xpress
Improper arm positioning during blood pressure measurement can lead to overestimations of up to 7 mmHg in systolic pressure, potentially altering patient diagnoses and treatment plans.
Cardiology October 14th 2024
GoodRx Health
Recent guidelines emphasize four primary medication classes for hypertension management, steering away from older options that may carry higher risks of side effects.